Upgrade to SI Premium - Free Trial

Amarin Corp. (AMRN) REDUCE-IT Study Met Primary Endpoint

September 24, 2018 6:17 AM
Amarin Corporation plc (NASDAQ: AMRN), announced today topline results from ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Corporate News FDA Hot Corp. News Hot FDA News Momentum Movers Trader Talk

Next Articles